We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGLN
1001
DELISTED
Magellan Health Services, Inc.
MGLN
$167K ﹤0.01%
+2,132
New +$150K
BPOP icon
1002
Popular Inc
BPOP
$11.1B
$166K ﹤0.01%
2,825
-52,698
-95% -$2.94M
CHEF icon
1003
Chefs' Warehouse
CHEF
$4.5B
$166K ﹤0.01%
+4,351
New +$158K
FOXA icon
1004
Fox Class A
FOXA
$26.9B
$166K ﹤0.01%
4,465
-131,853
-97% -$4.51M
ZEPP
1005
Zepp Health
ZEPP
$69.7M
$165K ﹤0.01%
+3,426
New +$144K
CPF icon
1006
Central Pacific Financial
CPF
$1B
$163K ﹤0.01%
+5,494
New +$160K
ATRO icon
1007
Astronics
ATRO
$3.84B
$162K ﹤0.01%
6,954
-106,120
-94% -$2.61M
XERS icon
1008
Xeris Biopharma Holdings
XERS
$1.45B
$161K ﹤0.01%
+22,871
New +$189K
AN icon
1009
AutoNation
AN
$6.92B
$160K ﹤0.01%
+3,282
New +$166K
PRI icon
1010
Primerica
PRI
$9.89B
$160K ﹤0.01%
1,222
-18,140
-94% -$2.34M
EVBG
1011
DELISTED
Everbridge, Inc. Common Stock
EVBG
$160K ﹤0.01%
+2,047
New +$158K
CMCT
1012
Creative Media & Community Trust
CMCT
$13M
– –
0
– –
LH icon
1013
Labcorp
LH
$25.9B
$159K ﹤0.01%
+1,094
New +$158K
ATEX icon
1014
Anterix
ATEX
$1.94B
$155K ﹤0.01%
3,581
-31,781
-90% -$1.3M
GLPI icon
1015
Gaming and Leisure Properties
GLPI
$12.8B
$151K ﹤0.01%
3,495
-12,459
-78% -$511K
OCSL icon
1016
Oaktree Specialty Lending
OCSL
$1.14B
$151K ﹤0.01%
+9,211
New +$145K
HAS icon
1017
Hasbro
HAS
$13.2B
$150K ﹤0.01%
1,423
-47,619
-97% -$4.96M
CYH icon
1018
Community Health Systems
CYH
$423M
$149K ﹤0.01%
51,526
-12,521
-20% -$43.4K
QDEL icon
1019
QuidelOrtho
QDEL
$838M
$149K ﹤0.01%
1,991
-133,858
-99% -$8.65M
WRLD icon
1020
World Acceptance Corp
WRLD
$873M
$149K ﹤0.01%
+1,719
New +$177K
CIVI
1021
DELISTED
Civitas Resources
CIVI
$147K ﹤0.01%
6,294
+5,918
+1,574% +$117K
JBGS
1022
JBG SMITH
JBGS
$708M
$147K ﹤0.01%
+3,686
New +$146K
BFYT
1023
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$146K ﹤0.01%
7,549
-52,784
-87% -$1.19M
AMG icon
1024
Affiliated Managers Group
AMG
$9.76B
$142K ﹤0.01%
1,679
-105,073
-98% -$8.62M
DAC icon
1025
Danaos Corp
DAC
$2.56B
$140K ﹤0.01%
+15,247
New +$147K
39 40
41
42 43

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.